Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.
| Revenue (Most Recent Fiscal Year) | $34.87M |
| Net Income (Most Recent Fiscal Year) | $-5.13M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.18 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.17 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -14.70% |
| Net Margin (Trailing 12 Months) | -13.88% |
| Return on Equity (Trailing 12 Months) | -21.25% |
| Return on Assets (Trailing 12 Months) | -16.89% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.25 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.19 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.43 |
| Book Value per Share (Most Recent Fiscal Quarter) | $4.98 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 4.56M |
| Free Float | 4.55M |
| Market Capitalization | $6.56M |
| Average Volume (Last 20 Days) | 0.12M |
| Beta (Past 60 Months) | 1.35 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 41.98% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |